Trial Profile
Prospective multiple-dose ascending study of PDC-APB in patients sensitive to poison ivy
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 30 Nov 2015
Price :
$35
*
At a glance
- Drugs PDC APB (Primary)
- Indications Contact dermatitis
- Focus Adverse reactions
- Sponsors Hapten Sciences
- 30 Nov 2015 New trial record